Modeling of Autism Using Organoid Technology.

Area of Science:

• Neuroscience
• Developmental Biology
• Genetics

Background:

• Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disease driven by multiple genetic mutations.
• Current stem cell models have limitations in fully recapitulating ASD pathogenesis.
• A need exists for advanced models to study ASD molecular pathways and mechanisms.

Purpose of the Study:

• To review the advantages of three-dimensional (3D) organoid systems for modeling autism.
• To explore the potential of combining 3D organoids with genome editing technologies for ASD research.

Main Methods:

• Review of existing literature on autism modeling using stem cells and organoids.
• Discussion of the application of Clustered Regularly Interspaced Short Palindromic Repeat-associated protein 9 (CRISPR/Cas9) gene editing in organoid systems.

Main Results:

• 3D organoid systems provide a more physiologically relevant platform for studying neurodevelopmental diseases like autism.
• Organoids can better mimic the complex cellular architecture and interactions relevant to ASD.
• CRISPR/Cas9 technology enables precise genetic manipulation within organoids to model specific autism-associated mutations.

Conclusions:

• 3D organoid systems represent a significant advancement in modeling autism pathogenesis.
• The integration of CRISPR/Cas9 with 3D organoids offers a powerful tool for dissecting the genetic underpinnings of autism.
• This combined approach holds great potential to accelerate the understanding and development of therapeutic strategies for autism.